Cite
HARVARD Citation
Ong, K. et al. (n.d.). Is the existing evidence about costs for outcomes associated with chlamydia sufficiently robust for economic evaluation of the National Chlamydia Screening Programme in England?. Lancet. pp. S60-. [Online].